Leading Kdion Injection (Phytomenadione)Supplier from INDIA to Washington, USA | City Drug Exporters
City Drug Exporters supplies Kdion Injection (Phytomenadione) from INDIA to Washington, USA. Trusted pharmaceutical exporter for wholesalers, distributors, pharmacies, and healthcare procurement companies
Kdion Injection (Phytomenadione) is a synthetic, fat-soluble form of naturally occurring Vitamin K1. Its primary pharmacological action is to promote the hepatic synthesis of blood-clotting proteins. It is used to treat vitamin K deficiency, manage anticoagulant-induced bleeding, and prevent hemorrhagic disease in newborns.
Mechanism of Action :
Activates Clotting Factors: It drives the carboxylation of glutamic acid residues in precursor proteins.
Synthesis in Liver: This converts inactive proteins into functional clotting factors.
Specific Factors Targeted: It targets Factors II (prothrombin), VII, IX, and X.
Natural Coagulation: This restores the blood's ability to form clots.
Pharmacokinetics :
Onset of Action: Noticeable improvement in clotting times occurs within 1 to 2 hours of administration.
Metabolism: Rapidly metabolized in the liver into inactive metabolites.
Excretion: Excreted primarily through bile and urine.
Half-life: The initial half-life after intravenous administration is approximately 22 minutes.
City Drug House Exporters provides:
Bulk supply for hospitals & distributors
Export to USA. Washington, INDIA
Regulatory documents (COA, MSDS, etc.)
Competitive pricing & reliable logistics
Contact for More Information :
📞 Contact City drug House Exporters from India
🌐 Websites:
https://www.citydrugexporters.com
📧 Email: citydrug123@gmail.com
📦 Business Type: Exporter | Bulk Supplier | Distributor
📲 WhatsApp: +91 9975390171
City Drug Exporters supplies Kdion Injection (Phytomenadione) from INDIA to Washington, USA. Trusted pharmaceutical exporter for wholesalers, distributors, pharmacies, and healthcare procurement companies
Kdion Injection (Phytomenadione) is a synthetic, fat-soluble form of naturally occurring Vitamin K1. Its primary pharmacological action is to promote the hepatic synthesis of blood-clotting proteins. It is used to treat vitamin K deficiency, manage anticoagulant-induced bleeding, and prevent hemorrhagic disease in newborns.
Mechanism of Action :
Activates Clotting Factors: It drives the carboxylation of glutamic acid residues in precursor proteins.
Synthesis in Liver: This converts inactive proteins into functional clotting factors.
Specific Factors Targeted: It targets Factors II (prothrombin), VII, IX, and X.
Natural Coagulation: This restores the blood's ability to form clots.
Pharmacokinetics :
Onset of Action: Noticeable improvement in clotting times occurs within 1 to 2 hours of administration.
Metabolism: Rapidly metabolized in the liver into inactive metabolites.
Excretion: Excreted primarily through bile and urine.
Half-life: The initial half-life after intravenous administration is approximately 22 minutes.
City Drug House Exporters provides:
Bulk supply for hospitals & distributors
Export to USA. Washington, INDIA
Regulatory documents (COA, MSDS, etc.)
Competitive pricing & reliable logistics
Contact for More Information :
📞 Contact City drug House Exporters from India
🌐 Websites:
https://www.citydrugexporters.com
📧 Email: citydrug123@gmail.com
📦 Business Type: Exporter | Bulk Supplier | Distributor
📲 WhatsApp: +91 9975390171
Keywords
